|
Sunday, 08/01/2010
|
Design and Analysis of a Simulation Study on MPLS Network
Wenbiao Zhang, Insurance Corporation of British Columbia; Pranesh Kumar, University of Northern British Columbia
3:05 PM
|
Comparing Methods of Estimating Treatment Effects on a Continuous Outcome in Multicenter Randomized Controlled Trials: A Simulation Study
Rong Chu, McMaster University; Lehana Thabane, McMaster University; Jinhui Ma, McMaster University; Eleanor Pullenayegum , McMaster University; Anne Holbrook, McMaster University
3:20 PM
|
Exploring Center Effects in Randomized Studies with Censored Endpoints
Richard McNally, Celgene Corporation; Sarah H. Kogut, Celgene Corporation
4:35 PM
|
Assessing the Causal Effect of Treatment Dosages in the Presence of Self-Selection
Xin Gao, University of Michigan; Michael R. Elliott, University of Michigan
5:05 PM
|
Design of Nonrandomized Medical Device Trials Based on Subclassification Using Propensity Score Quintiles
Greg Maislin, Biomedical Statistical Consulting; Donald B. Rubin, Harvard University
5:25 PM
|
|
Monday, 08/02/2010
|
Health, Disability, and Employment Status Effects of a Diabetes Management Life Coaching and Pharmacist Counseling Intervention
Tammy Tom, The University of Hawaii
|
Multiple Imputation for causal Inference
Irina Bondarenko, University of Michigan; Trivellore Raghunathan, University of Michigan
8:50 AM
|
Randomized Experiments for Measuring Display Advertising Effectiveness
Taylan Yildiz, Google; Nicolas Remy, Google
9:05 AM
|
Robust Covariate Control in Cluster-Randomized Trials with MPLUS and WinBUGS
Jiaquan Fan, Westat
9:05 AM
|
Evaluation of Common Statistical Methods in Randomized Delayed-Start Design of Progression Disease Clinical Trials
Bongin Yoo, Bristol-Myers Squibb; Thomas Kelleher, Bristol-Myers Squibb
9:35 AM
|
Constrained Randomization Within Group-Randomized Trials: Implications for Comparative Effectiveness Research
Paul J. Nietert, Medical University of South Carolina; Ruth G. Jenkins, Medical University of South Carolina; Lynne S. Nemeth, Medical University of South Carolina; Andrea M. Wessell, Medical University of South Carolina; Peter M. Miller, Medical University of South Carolina; Steven M. Ornstein, Medical University of South Carolina
11:05 AM
|
Generalizing Evidence from Randomized Clinical Trials to Target Populations: The ACTG-320 Trial
Elizabeth Stuart, Johns Hopkins Bloomberg School of Public Health; Stephen R. Cole, The University of North Carolina at Chapel Hill
2:05 PM
|
Conditional Independence Proofs for Generalizability
Sue Marcus, Columbia University
2:30 PM
|
|
Tuesday, 08/03/2010
|
Improving Small-Sample Inference in Group-Randomized Trials with Binary Outcomes
Philip Westgate, University of Michigan; Thomas Braun, University of Michigan
|
Bounds on Controlled Direct Effects Under Monotonic Assumptions About Mediators and Confounders
Yasutaka Chiba, Kinki University School of Medicine
|
Using Statistical Concepts to Determine Risk Level of Randomized Clinical Trials That Compare Two Noninvestigational Therapies
Martin L. Lesser, Feinstein Institute for Medical Research; Nina E. Kohn, Feinstein Institute for Medical Research
|
A Multilevel Modeling Approach to Investigating Treatment Effect Variability in Randomized Longitudinal Experiments
Joseph Rausch, University of Cincinnati College of Medicine/Cincinnati Children's Hospital
9:15 AM
|
Propensity Score Matching in Randomized Clinical Trials
Zhenzhen Xu, University of Michigan; John David Kalbfleisch, University of Michigan
9:20 AM
|
Inference for Changes in the Kappa Statistic in Multi-level Clustered Binary Data
Rebecca Roberts Andridge, The Ohio State University
10:35 AM
|
Imputation Strategies for Missing Binary Outcomes in Cluster Randomized Trials
Jinhui Ma, McMaster University; Noori Akhtar-Danesh, McMaster University; Lisa Dolovich, McMaster University; Lehana Thabane, McMaster University
2:35 PM
|
Inference for Treatment Efficacy on Survival Probability in Randomized Clinical Trials with Noncompliance
Ying Zhou, University of California, Los Angeles
3:05 PM
|
|
Wednesday, 08/04/2010
|
Individually Randomized Group Treatment (IRGT) Trials in HIV/AIDS: How Often Is the Intraclass Correlation Ignored in Design and Analysis?
Sherri L. Pals, CDC; Ryan E. Wiegand, CDC; David Murray, The Ohio State University
8:35 AM
|
Group-Randomized Trials (GRT) in HIV/AIDS Research: How Often Is the Intraclass Correlation Ignored in Design and Analysis?
Ryan E. Wiegand, CDC; Sherri L. Pals, CDC; David Murray, The Ohio State University
8:55 AM
|
A Comparison of Two Methods for Analyzing Data from a Methodological Study of Paper-and-Pencil vs. Web-Based Survey Administration: Sample Survey and Group Randomized Trial
Maxine M. Denniston, CDC; Danice K. Eaton, CDC; Sherri L. Pals, CDC
9:15 AM
|
Optimal G-Estimation Mediation Analyses Under Departure from Sequential Ignorability
Rongmei Zhang, University of Pennsylvania; Marshall M. Joffe, University of Pennsylvania; Thomas R. Ten Have, University of Pennsylvania School of Medicine
9:15 AM
|
Bayesian Design for Nonrandomized Phase II Oncology Trials
Yanmei Xu, GlaxoSmithKline; Bingming Yi, GlaxoSmithKline
10:55 AM
|
An Adaptive Futility Monitoring Method with Time-Varying Conditional Power Boundary
Ying Zhang, The University of Iowa; William Clarke, The University of Iowa
10:55 AM
|
Cancer Risk in the Environment: Public Policy Issues in Screening
Karen Kafadar, Indiana University; Philip Prorok, National Cancer Institute
11:05 AM
|
Sensitivity Analyses Adjusting for Early Discontinuation of Study Medication in the RE-LY Trial: An Open-Label, Randomized, Active-Controlled, Time-to-Event Noninferiority Trial
Xiuyu Cong, Boehringer Ingelheim Pharmaceuticals, Inc.; Qiqi Deng, Boehringer Ingelheim Pharmaceuticals, Inc.; Susan Q. Wang, Boehringer Ingelheim Pharmaceuticals, Inc.
11:15 AM
|
Control Group Bias in RCTs: Methodologic Issues with Application to Atypical Antipsychotic Trials in Schizophrenia
Robert Makuch, Yale University; Ralitza Gueorguieva, Yale University; Scott Woods, Yale University; Scott Woods, Yale University
11:35 AM
|
Weighted Randomization Test for Multi-Arm Randomized Clinical Trials
Feifang Hu, University of Virginia
3:05 PM
|
|